BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 23028135)

  • 1. Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes.
    Pietropaolo M; Towns R; Eisenbarth GS
    Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective role of anti-idiotypic antibodies in autoimmunity--lessons for type 1 diabetes.
    Hampe CS
    Autoimmunity; 2012 Jun; 45(4):320-31. PubMed ID: 22288464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of humoral beta-cell autoimmunity in type 1 diabetes.
    Knip M; Siljander H; Ilonen J; Simell O; Veijola R
    Pediatr Diabetes; 2016 Jul; 17 Suppl 22():17-24. PubMed ID: 27411432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule.
    Christen U; Kimmel R
    Front Endocrinol (Lausanne); 2020; 11():591083. PubMed ID: 33193102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experiments by nature: lessons on type 1 diabetes.
    Battaglia M
    Tissue Antigens; 2014 Jan; 83(1):1-9. PubMed ID: 24355002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin and type 1 diabetes: immune connections.
    Culina S; Brezar V; Mallone R
    Eur J Endocrinol; 2013 Feb; 168(2):R19-31. PubMed ID: 23065992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond the hormone: insulin as an autoimmune target in type 1 diabetes.
    Brezar V; Carel JC; Boitard C; Mallone R
    Endocr Rev; 2011 Oct; 32(5):623-69. PubMed ID: 21700723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
    Durinovic-Belló I
    Autoimmunity; 1998; 27(3):159-77. PubMed ID: 9609134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives.
    Mallone R; Brezar V; Boitard C
    Clin Dev Immunol; 2011; 2011():513210. PubMed ID: 21785617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal T-cell autoreactivity is amplified in overweight children with new-onset insulin-requiring diabetes.
    Buryk MA; Dosch HM; Libman I; Arena VC; Huang Y; Cheung RK; Trucco M; Pietropaolo M; Becker DJ
    Diabetes Care; 2015 Jan; 38(1):43-50. PubMed ID: 25414154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.
    Skyler JS; Pugliese A
    Diabetes Technol Ther; 2013 Jun; 15 Suppl 2(Suppl 2):S2-13-S2-20. PubMed ID: 23786294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin as a key autoantigen in the development of type 1 diabetes.
    Nakayama M
    Diabetes Metab Res Rev; 2011 Nov; 27(8):773-7. PubMed ID: 22069258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin secretion and sensitivity in the prediction of type 1 diabetes in children with advanced β-cell autoimmunity.
    Siljander HT; Hermann R; Hekkala A; Lähde J; Tanner L; Keskinen P; Ilonen J; Simell O; Veijola R; Knip M
    Eur J Endocrinol; 2013 Oct; 169(4):479-85. PubMed ID: 23904276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune mechanisms in type 1 diabetes.
    Knip M; Siljander H
    Autoimmun Rev; 2008 Jul; 7(7):550-7. PubMed ID: 18625444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell responses to hybrid insulin peptides prior to type 1 diabetes development.
    Mitchell AM; Alkanani AA; McDaniel KA; Pyle L; Waugh K; Steck AK; Nakayama M; Yu L; Gottlieb PA; Rewers MJ; Michels AW
    Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33542101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The case for an autoimmune aetiology of type 1 diabetes.
    Mannering SI; Pathiraja V; Kay TW
    Clin Exp Immunol; 2016 Jan; 183(1):8-15. PubMed ID: 26313217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet autoimmunity identifies a unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetes.
    Subauste A; Gianani R; Chang AM; Plunkett C; Pietropaolo SL; Zhang YJ; Barinas-Mitchell E; Kuller LH; Galecki A; Halter JB; Pietropaolo M
    PLoS One; 2014; 9(9):e106537. PubMed ID: 25226365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic islet autoimmunity.
    Boitard C
    Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes.
    Pearson JA; Wong FS; Wen L
    J Autoimmun; 2016 Jan; 66():76-88. PubMed ID: 26403950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-cell autoimmunity.
    Fuchs YF; Adler K; Bonifacio E
    Methods Mol Biol; 2012; 933():265-74. PubMed ID: 22893413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.